In the BioHarmony Drug Report Database
Delatestryl, Xyosted (testosterone enanthate) is a small molecule pharmaceutical. Testosterone enanthate was first approved as Delatestryl on 1982-01-01. It is used to treat breast neoplasms, delayed puberty, and hypogonadism in the USA. Testosterone enanthate’s patents are valid until 2038-08-30 (FDA).
Image (chem structure or protein)